Buy MOUNJARO 2.5MG 0.5ML Online in USA - Lowest Price $440.00
Configure Prescription
About MOUNJARO 2.5MG 0.5ML
Mounjaro 2.5MG/0.5ML Injection contains tirzepatide, a once-weekly injectable medicine used to improve blood sugar control in adults with type 2 diabetes. It is also used as a starting dose to support gradual dose escalation and may aid in weight reduction under medical supervision.
What is it used for?
Mounjaro 2.5MG/0.5ML is a prefilled subcutaneous injection containing tirzepatide, developed by Eli Lilly and Company. It belongs to a class of medicines known as dual GIP and GLP-1 receptor agonists.
Tirzepatide works by:
- Stimulating insulin release when blood sugar levels are elevated
- Reducing glucose production by the liver
- Slowing gastric emptying
- Decreasing appetite
These combined effects help improve blood glucose control and may lead to weight loss in many patients.
The 2.5MG dose is typically used as a starting dose for the first 4 weeks to allow the body to adjust to the medication and reduce gastrointestinal side effects. It is administered once weekly under the skin (abdomen, thigh, or upper arm), with or without food.
Mounjaro is not indicated for type 1 diabetes and should be used strictly under medical supervision along with diet and exercise.
How to use
- Type 2 diabetes mellitus (blood sugar control)
- Initial dose for dose-escalation therapy
- Weight management in adults with type 2 diabetes (as prescribed)
Side Effects
Common side effects may include:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Decreased appetite
- Indigestion
Serious but rare side effects:
- Pancreatitis (severe abdominal pain)
- Gallbladder problems
- Low blood sugar (especially when used with insulin or sulfonylureas)
- Allergic reactions
- Possible thyroid tumor risk (in predisposed individuals)
